These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3019236)

  • 61. Synthesis and antiviral activity of certain thiazole C-nucleosides.
    Srivastava PC; Pickering MV; Allen LB; Streeter DG; Campbell MT; Witkowski JT; Sidwell RW; Robins RK
    J Med Chem; 1977 Feb; 20(2):256-62. PubMed ID: 189032
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Contributing factor to Mycoplasma pneumoniae produced stimulation of rhinovirus-RNA synthesis.
    Fletcher RD; Milligan WH; Albertson JN
    Folia Microbiol (Praha); 1970; 15(5):325-9. PubMed ID: 4320382
    [No Abstract]   [Full Text] [Related]  

  • 63. Synthesis of new 3-methylthio-5-aryl-4-isothiazolecarbonitriles with broad antiviral spectrum.
    Cutrì CC; Garozzo A; Siracusa MA; Castro A; Tempera G; Sarvà MC; Guerrera F
    Antiviral Res; 2002 Aug; 55(2):357-68. PubMed ID: 12103435
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of certain amino acids on reproduction of encephalomyocarditis virus. I. Investigation of the inhibiting effect of L-lysine.
    Medvedkina OA; Maslova SV; Shirman GA
    Arch Gesamte Virusforsch; 1972; 37(2):191-202. PubMed ID: 4337543
    [No Abstract]   [Full Text] [Related]  

  • 65. Labeling of capsid proteins and genomic RNA of human rhinovirus with two different fluorescent dyes for selective detection by capillary electrophoresis.
    Kremser L; Petsch M; Blaas D; Kenndler E
    Anal Chem; 2004 Dec; 76(24):7360-5. PubMed ID: 15595880
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antipicornavirus flavone Ro 09-0179.
    Ishitsuka H; Ohsawa C; Ohiwa T; Umeda I; Suhara Y
    Antimicrob Agents Chemother; 1982 Oct; 22(4):611-6. PubMed ID: 6295260
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine.
    Khare GP; Sidwell RW; Huffman JH; Tolman RL; Robins RK
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):880-4. PubMed ID: 4339065
    [No Abstract]   [Full Text] [Related]  

  • 68. Antiviral activity of constituents of Tamus communis.
    Aquino R; Conti C; De Simone F; Orsi N; Pizza C; Stein ML
    J Chemother; 1991 Oct; 3(5):305-9. PubMed ID: 1667189
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Some compounds active as antirhinovirus in the plaque inhibition test.
    Runti C
    J Med Chem; 1968 Jul; 11(4):897-9. PubMed ID: 4299535
    [No Abstract]   [Full Text] [Related]  

  • 70. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
    Speelman B; Brooks BR; Post CB
    Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Replication of rhinoviruses.
    Butterworth BE; Grunert RR; Korant BD; Lonberg-Holm K; Yin FH
    Arch Virol; 1976; 51(3):169-89. PubMed ID: 61746
    [No Abstract]   [Full Text] [Related]  

  • 72. Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
    Dewindt B; van Eemeren K; Andries K
    Antiviral Res; 1994 Sep; 25(1):67-72. PubMed ID: 7811059
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A 'new' generation of more potent synthetic antirhinovirus compounds: comparison of their MICs and their synergistic interactions.
    Al-Nakib W; Tyrrell DA
    Antiviral Res; 1987 Nov; 8(4):179-87. PubMed ID: 2833156
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule.
    Crump CE; Arruda E; Hayden FG
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1425-7. PubMed ID: 7916558
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Progress with antiviral agents.
    Shugar D
    FEBS Lett; 1974 Mar; 40(0):suppl:S48-62. PubMed ID: 4137135
    [No Abstract]   [Full Text] [Related]  

  • 77. 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
    Kelley JL; Linn JA; Krochmal MP; Selway JW
    J Med Chem; 1988 Oct; 31(10):2001-4. PubMed ID: 2845083
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ribonuclease from
    Shah Mahmud R; Müller C; Romanova Y; Mostafa A; Ulyanova V; Pleschka S; Ilinskaya O
    Biomed Res Int; 2017; 2017():5279065. PubMed ID: 28546965
    [No Abstract]   [Full Text] [Related]  

  • 79. Mechanism of action of a pestivirus antiviral compound.
    Baginski SG; Pevear DC; Seipel M; Sun SC; Benetatos CA; Chunduru SK; Rice CM; Collett MS
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7981-6. PubMed ID: 10869440
    [TBL] [Abstract][Full Text] [Related]  

  • 80. On a new inhibition of poliovirus RNA replication.
    Bucchini D; Fiszman M; Girard M
    Intervirology; 1974; 3(5-6):281-91. PubMed ID: 4374448
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.